Listed

Fresenius Medical Care AG: Form 20-F for the period ended Dec 31, 2013

Filed with the SEC on Feb 25, 2014 and accepted by EDGAR at Feb 25, 2014, 14:08 ET.

Share

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2013-01-01 to 2013-12-31$4.97bnus-gaap:Revenues
Cost of revenue12 months2013-01-01 to 2013-12-31$9.87bnus-gaap:CostOfRevenue
Gross profit12 months2013-01-01 to 2013-12-31$4.74bnus-gaap:GrossProfit
Research and development12 months2013-01-01 to 2013-12-31$125.8mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative12 months2013-01-01 to 2013-12-31$2.39bnus-gaap:SellingGeneralAndAdministrativeExpense
Operating income12 months2013-01-01 to 2013-12-31$2.26bnus-gaap:OperatingIncomeLoss
Interest expense12 months2013-01-01 to 2013-12-31$447.5mus-gaap:InterestExpense
Income tax12 months2013-01-01 to 2013-12-31$592.0mus-gaap:IncomeTaxExpenseBenefit
Net income12 months2013-01-01 to 2013-12-31$1.11bnus-gaap:NetIncomeLoss
Diluted EPS12 months2013-01-01 to 2013-12-31$3.65us-gaap:EarningsPerShareDiluted
Basic EPS12 months2013-01-01 to 2013-12-31$3.65us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2013-01-01 to 2013-12-31302,550,392 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2013-01-01 to 2013-12-31$2.03bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2013-01-01 to 2013-12-31$747.9mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid12 months2013-01-01 to 2013-12-31$296.1mus-gaap:PaymentsOfDividends
Cash and equivalentsAt period end2013-12-31$682.8mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2013-12-31$6.29bnus-gaap:AssetsCurrent
Total assetsAt period end2013-12-31$23.12bnus-gaap:Assets
Current liabilitiesAt period end2013-12-31$3.55bnus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2013-12-31$12.99bnus-gaap:Liabilities
Long-term debtAt period end2013-12-31$7.75bnus-gaap:LongTermDebtNoncurrent
Short-term borrowingsAt period end2013-12-31$96.6mus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2013-12-31$9.23bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001047469-14-001301. Last ingested by Listed: Nov 14, 2026, 17:40 ET. Listed shows no prices and gives no investment advice.